Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Other Operating Expenses: 2017-2024

Historic Other Operating Expenses for Puma Biotechnology (PBYI) over the last 8 years, with Dec 2024 value amounting to $64.4 million.

  • Puma Biotechnology's Other Operating Expenses fell 58.16% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.0 million, marking a year-over-year decrease of 34.56%. This contributed to the annual value of $64.4 million for FY2024, which is 2.75% up from last year.
  • According to the latest figures from FY2024, Puma Biotechnology's Other Operating Expenses is $64.4 million, which was up 2.75% from $62.7 million recorded in FY2023.
  • Puma Biotechnology's 5-year Other Operating Expenses high stood at $64.4 million for FY2024, and its period low was $39.4 million during FY2020.
  • Its 3-year average for Other Operating Expenses is $58.9 million, with a median of $62.7 million in 2023.
  • As far as peak fluctuations go, Puma Biotechnology's Other Operating Expenses skyrocketed by 61.78% in 2021, and later declined by 22.08% in 2022.
  • Over the past 5 years, Puma Biotechnology's Other Operating Expenses (Yearly) stood at $39.4 million in 2020, then skyrocketed by 61.78% to $63.7 million in 2021, then decreased by 22.08% to $49.6 million in 2022, then rose by 26.28% to $62.7 million in 2023, then rose by 2.75% to $64.4 million in 2024.